procaspase 8 antibody blocking peptide Search Results


96
Santa Cruz Biotechnology caspase 8
Caspase 8, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/procaspase+8+antibody+blocking+peptide/caspase-8+Antibody/10__1042_slash_bj3470669-37-100-116
Average 96 stars, based on 1 article reviews
caspase 8 - by Bioz Stars, 2026-08
96/100 stars
  Buy from Supplier

96
Santa Cruz Biotechnology procaspase 8
Procaspase 8, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/procaspase+8+antibody+blocking+peptide/caspase-3+Antibody/pmc02847319-56-22-24
Average 96 stars, based on 1 article reviews
procaspase 8 - by Bioz Stars, 2026-08
96/100 stars
  Buy from Supplier

90
MBL International procaspase-8
Procaspase 8, supplied by MBL International, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/procaspase+8+antibody+blocking+peptide/procaspase+8/pmc02670318-75-37-38
Average 90 stars, based on 1 article reviews
procaspase-8 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
MBL Life science anti-procaspase-8 (5f7
Anti Procaspase 8 (5f7, supplied by MBL Life science, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/procaspase+8+antibody+blocking+peptide/anti+caspase+8/pm16052233-183-12-19
Average 90 stars, based on 1 article reviews
anti-procaspase-8 (5f7 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Immunotec inc mouse monoclonal abs against human procaspase-8 antibody
Mouse Monoclonal Abs Against Human Procaspase 8 Antibody, supplied by Immunotec inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/procaspase+8+antibody+blocking+peptide/mouse+anti+human+procaspase+8+antibodies/10__1074_slash_jbc__m304896200-59-62-68
Average 90 stars, based on 1 article reviews
mouse monoclonal abs against human procaspase-8 antibody - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology c20 goat polyclonal anti procaspase 8 p18 antibody
C20 Goat Polyclonal Anti Procaspase 8 P18 Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/procaspase+8+antibody+blocking+peptide/p18+Antibody/10__1186_slash_1476___511x___10___73-99-15-9
Average 93 stars, based on 1 article reviews
c20 goat polyclonal anti procaspase 8 p18 antibody - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

90
Becton Dickinson polyclonal antibody procaspase-8
Figure 1. Identification of an interaction between Caspase-8 and Crk proteins. (A) Serum starved NB7 (Casp8−/−) and NB7C8 (Casp8 reconstituted) cells were trypsinized and held in suspension (Susp) or allowed to attach to fibronectin for 10, 30, or 60 min and lysates probed with indicated antibodies. (B) NB7C8 cells were subjected to immunoprecipitation with antisera to caspase-8 after spreading on a fibronectin substrate for 30 min (FN), or after being held in suspension (Susp) and probed for indicated proteins. (C) Similarly treated NB7C8 cells were subjected to Crk protein-immunoprecipitation and immunoblotting for the proteins indicated. NB7 cells with genetic deletion of caspase-8 were used as controls to clearly differentiate the <t>procaspase-8</t> band from precipitating Ig. (D) Immobilized recombinant SH2 domains of Crk-I/II, CrkL or Syk were probed with recombinant caspase-8 catalytic domain treated with recombinant Src kinase (phosphocasp-8) or not (casp-8) (mean ± SE, *P < 0.01). (E) Recombinant SH2 domains of Crk-II and CrkL were used in pulldown assays, and the precipitants resolved and probed for indicated proteins. (F) Lysates prepared as in (A) expressing control shRNA or shRNA against CrkL. (G) NB7 or NB7C8 cells expressing CrkL shRNA or control shRNA were analyzed for their ability to migrate in a wound assay for four hours (n = 40/group, mean ± SE, *P < 0.01).
Polyclonal Antibody Procaspase 8, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/procaspase+8+antibody+blocking+peptide/polyclonal+antibody+procaspase+8/pmc03739813-289-7-8
Average 90 stars, based on 1 article reviews
polyclonal antibody procaspase-8 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

96
Cell Signaling Technology Inc procaspase 8
Figure 1. Identification of an interaction between Caspase-8 and Crk proteins. (A) Serum starved NB7 (Casp8−/−) and NB7C8 (Casp8 reconstituted) cells were trypsinized and held in suspension (Susp) or allowed to attach to fibronectin for 10, 30, or 60 min and lysates probed with indicated antibodies. (B) NB7C8 cells were subjected to immunoprecipitation with antisera to caspase-8 after spreading on a fibronectin substrate for 30 min (FN), or after being held in suspension (Susp) and probed for indicated proteins. (C) Similarly treated NB7C8 cells were subjected to Crk protein-immunoprecipitation and immunoblotting for the proteins indicated. NB7 cells with genetic deletion of caspase-8 were used as controls to clearly differentiate the <t>procaspase-8</t> band from precipitating Ig. (D) Immobilized recombinant SH2 domains of Crk-I/II, CrkL or Syk were probed with recombinant caspase-8 catalytic domain treated with recombinant Src kinase (phosphocasp-8) or not (casp-8) (mean ± SE, *P < 0.01). (E) Recombinant SH2 domains of Crk-II and CrkL were used in pulldown assays, and the precipitants resolved and probed for indicated proteins. (F) Lysates prepared as in (A) expressing control shRNA or shRNA against CrkL. (G) NB7 or NB7C8 cells expressing CrkL shRNA or control shRNA were analyzed for their ability to migrate in a wound assay for four hours (n = 40/group, mean ± SE, *P < 0.01).
Procaspase 8, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/procaspase+8+antibody+blocking+peptide/Cleaved+Caspase-8+(Asp374)+Rabbit+mAb/pm37573655-70-51-57
Average 96 stars, based on 1 article reviews
procaspase 8 - by Bioz Stars, 2026-08
96/100 stars
  Buy from Supplier

97
Cell Signaling Technology Inc anti procaspase 8
Figure 1. Identification of an interaction between Caspase-8 and Crk proteins. (A) Serum starved NB7 (Casp8−/−) and NB7C8 (Casp8 reconstituted) cells were trypsinized and held in suspension (Susp) or allowed to attach to fibronectin for 10, 30, or 60 min and lysates probed with indicated antibodies. (B) NB7C8 cells were subjected to immunoprecipitation with antisera to caspase-8 after spreading on a fibronectin substrate for 30 min (FN), or after being held in suspension (Susp) and probed for indicated proteins. (C) Similarly treated NB7C8 cells were subjected to Crk protein-immunoprecipitation and immunoblotting for the proteins indicated. NB7 cells with genetic deletion of caspase-8 were used as controls to clearly differentiate the <t>procaspase-8</t> band from precipitating Ig. (D) Immobilized recombinant SH2 domains of Crk-I/II, CrkL or Syk were probed with recombinant caspase-8 catalytic domain treated with recombinant Src kinase (phosphocasp-8) or not (casp-8) (mean ± SE, *P < 0.01). (E) Recombinant SH2 domains of Crk-II and CrkL were used in pulldown assays, and the precipitants resolved and probed for indicated proteins. (F) Lysates prepared as in (A) expressing control shRNA or shRNA against CrkL. (G) NB7 or NB7C8 cells expressing CrkL shRNA or control shRNA were analyzed for their ability to migrate in a wound assay for four hours (n = 40/group, mean ± SE, *P < 0.01).
Anti Procaspase 8, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/procaspase+8+antibody+blocking+peptide/Caspase-1+Antibody/pmc02785162-223-30-32
Average 97 stars, based on 1 article reviews
anti procaspase 8 - by Bioz Stars, 2026-08
97/100 stars
  Buy from Supplier

90
Becton Dickinson monoclonal antibodies procaspase 8 procaspase 3
Figure 1. Identification of an interaction between Caspase-8 and Crk proteins. (A) Serum starved NB7 (Casp8−/−) and NB7C8 (Casp8 reconstituted) cells were trypsinized and held in suspension (Susp) or allowed to attach to fibronectin for 10, 30, or 60 min and lysates probed with indicated antibodies. (B) NB7C8 cells were subjected to immunoprecipitation with antisera to caspase-8 after spreading on a fibronectin substrate for 30 min (FN), or after being held in suspension (Susp) and probed for indicated proteins. (C) Similarly treated NB7C8 cells were subjected to Crk protein-immunoprecipitation and immunoblotting for the proteins indicated. NB7 cells with genetic deletion of caspase-8 were used as controls to clearly differentiate the <t>procaspase-8</t> band from precipitating Ig. (D) Immobilized recombinant SH2 domains of Crk-I/II, CrkL or Syk were probed with recombinant caspase-8 catalytic domain treated with recombinant Src kinase (phosphocasp-8) or not (casp-8) (mean ± SE, *P < 0.01). (E) Recombinant SH2 domains of Crk-II and CrkL were used in pulldown assays, and the precipitants resolved and probed for indicated proteins. (F) Lysates prepared as in (A) expressing control shRNA or shRNA against CrkL. (G) NB7 or NB7C8 cells expressing CrkL shRNA or control shRNA were analyzed for their ability to migrate in a wound assay for four hours (n = 40/group, mean ± SE, *P < 0.01).
Monoclonal Antibodies Procaspase 8 Procaspase 3, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/procaspase+8+antibody+blocking+peptide/monoclonal+antibodies+procaspase+8+procaspase+3/10__1074_slash_jbc__m109__057638-49-89-97
Average 90 stars, based on 1 article reviews
monoclonal antibodies procaspase 8 procaspase 3 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

91
Novus Biologicals procaspase 8 antibody blocking peptide
Figure 1. Identification of an interaction between Caspase-8 and Crk proteins. (A) Serum starved NB7 (Casp8−/−) and NB7C8 (Casp8 reconstituted) cells were trypsinized and held in suspension (Susp) or allowed to attach to fibronectin for 10, 30, or 60 min and lysates probed with indicated antibodies. (B) NB7C8 cells were subjected to immunoprecipitation with antisera to caspase-8 after spreading on a fibronectin substrate for 30 min (FN), or after being held in suspension (Susp) and probed for indicated proteins. (C) Similarly treated NB7C8 cells were subjected to Crk protein-immunoprecipitation and immunoblotting for the proteins indicated. NB7 cells with genetic deletion of caspase-8 were used as controls to clearly differentiate the <t>procaspase-8</t> band from precipitating Ig. (D) Immobilized recombinant SH2 domains of Crk-I/II, CrkL or Syk were probed with recombinant caspase-8 catalytic domain treated with recombinant Src kinase (phosphocasp-8) or not (casp-8) (mean ± SE, *P < 0.01). (E) Recombinant SH2 domains of Crk-II and CrkL were used in pulldown assays, and the precipitants resolved and probed for indicated proteins. (F) Lysates prepared as in (A) expressing control shRNA or shRNA against CrkL. (G) NB7 or NB7C8 cells expressing CrkL shRNA or control shRNA were analyzed for their ability to migrate in a wound assay for four hours (n = 40/group, mean ± SE, *P < 0.01).
Procaspase 8 Antibody Blocking Peptide, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/procaspase+8+antibody+blocking+peptide/Caspase-8+Antibody+Blocking+Peptide/pmc08772724-177-1-5
Average 91 stars, based on 1 article reviews
procaspase 8 antibody blocking peptide - by Bioz Stars, 2026-08
91/100 stars
  Buy from Supplier

Image Search Results


Figure 1. Identification of an interaction between Caspase-8 and Crk proteins. (A) Serum starved NB7 (Casp8−/−) and NB7C8 (Casp8 reconstituted) cells were trypsinized and held in suspension (Susp) or allowed to attach to fibronectin for 10, 30, or 60 min and lysates probed with indicated antibodies. (B) NB7C8 cells were subjected to immunoprecipitation with antisera to caspase-8 after spreading on a fibronectin substrate for 30 min (FN), or after being held in suspension (Susp) and probed for indicated proteins. (C) Similarly treated NB7C8 cells were subjected to Crk protein-immunoprecipitation and immunoblotting for the proteins indicated. NB7 cells with genetic deletion of caspase-8 were used as controls to clearly differentiate the procaspase-8 band from precipitating Ig. (D) Immobilized recombinant SH2 domains of Crk-I/II, CrkL or Syk were probed with recombinant caspase-8 catalytic domain treated with recombinant Src kinase (phosphocasp-8) or not (casp-8) (mean ± SE, *P < 0.01). (E) Recombinant SH2 domains of Crk-II and CrkL were used in pulldown assays, and the precipitants resolved and probed for indicated proteins. (F) Lysates prepared as in (A) expressing control shRNA or shRNA against CrkL. (G) NB7 or NB7C8 cells expressing CrkL shRNA or control shRNA were analyzed for their ability to migrate in a wound assay for four hours (n = 40/group, mean ± SE, *P < 0.01).

Journal: Cell Adhesion & Migration

Article Title: Src-inducible association of CrkL with procaspase-8 promotes cell migration

doi: 10.4161/cam.25284

Figure Lengend Snippet: Figure 1. Identification of an interaction between Caspase-8 and Crk proteins. (A) Serum starved NB7 (Casp8−/−) and NB7C8 (Casp8 reconstituted) cells were trypsinized and held in suspension (Susp) or allowed to attach to fibronectin for 10, 30, or 60 min and lysates probed with indicated antibodies. (B) NB7C8 cells were subjected to immunoprecipitation with antisera to caspase-8 after spreading on a fibronectin substrate for 30 min (FN), or after being held in suspension (Susp) and probed for indicated proteins. (C) Similarly treated NB7C8 cells were subjected to Crk protein-immunoprecipitation and immunoblotting for the proteins indicated. NB7 cells with genetic deletion of caspase-8 were used as controls to clearly differentiate the procaspase-8 band from precipitating Ig. (D) Immobilized recombinant SH2 domains of Crk-I/II, CrkL or Syk were probed with recombinant caspase-8 catalytic domain treated with recombinant Src kinase (phosphocasp-8) or not (casp-8) (mean ± SE, *P < 0.01). (E) Recombinant SH2 domains of Crk-II and CrkL were used in pulldown assays, and the precipitants resolved and probed for indicated proteins. (F) Lysates prepared as in (A) expressing control shRNA or shRNA against CrkL. (G) NB7 or NB7C8 cells expressing CrkL shRNA or control shRNA were analyzed for their ability to migrate in a wound assay for four hours (n = 40/group, mean ± SE, *P < 0.01).

Article Snippet: Cells were stained with polyclonal antibody to procaspase-8 (BD Biosciences) (1:100) or mouse anti-CrkL antibody (BD Biosciences) (1:100) for 2 h. After multiple PBS/BSA washes, cells were exposed to respective Alexa Fluor conjugated secondary antibodies (1:250).

Techniques: Immunoprecipitation, Western Blot, Recombinant, Expressing, shRNA

Figure 2. CrkL promotes recruitment of caspase-8 to the periphery. (A) NB7C8 cells expressing CrkL shRNA or control shRNA were allowed to spread on fibronectin coated coverslips, then fixed cells were stained for procaspase-8 and with phalloidin to identify actin-rich adhesion ruffles, then imaged by confocal microscopy. Representative images are shown. Scale bars indicate 10 μm. (B) Recruitment of caspase-8 to adhesion ruffles was evaluated (n = 20/group, mean ± SE, *P < 0.01). (C) NB7C8 cells were allowed to attach to fibronectin-coated plates for 30 min before sequential isolation of cytosolic or focal adhesion complex containing fractions and immunoblot analysis. Bars indicate ratio of caspase-8 to FAK (C8:FAK) as normalized to “control” shRNA, as determined by densitometry via ImageJ software from NIH (n = 2/group, mean ± SE, *P < 0.05).

Journal: Cell Adhesion & Migration

Article Title: Src-inducible association of CrkL with procaspase-8 promotes cell migration

doi: 10.4161/cam.25284

Figure Lengend Snippet: Figure 2. CrkL promotes recruitment of caspase-8 to the periphery. (A) NB7C8 cells expressing CrkL shRNA or control shRNA were allowed to spread on fibronectin coated coverslips, then fixed cells were stained for procaspase-8 and with phalloidin to identify actin-rich adhesion ruffles, then imaged by confocal microscopy. Representative images are shown. Scale bars indicate 10 μm. (B) Recruitment of caspase-8 to adhesion ruffles was evaluated (n = 20/group, mean ± SE, *P < 0.01). (C) NB7C8 cells were allowed to attach to fibronectin-coated plates for 30 min before sequential isolation of cytosolic or focal adhesion complex containing fractions and immunoblot analysis. Bars indicate ratio of caspase-8 to FAK (C8:FAK) as normalized to “control” shRNA, as determined by densitometry via ImageJ software from NIH (n = 2/group, mean ± SE, *P < 0.05).

Article Snippet: Cells were stained with polyclonal antibody to procaspase-8 (BD Biosciences) (1:100) or mouse anti-CrkL antibody (BD Biosciences) (1:100) for 2 h. After multiple PBS/BSA washes, cells were exposed to respective Alexa Fluor conjugated secondary antibodies (1:250).

Techniques: Expressing, shRNA, Staining, Confocal Microscopy, Isolation, Western Blot, Software